Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.
GU ASCO annual meeting featured a presentation by Dr. David Benjamin discussing the state of the genitourinary medical oncology workforce in the United States in 2024. There are approximately 13,400 ...
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025) Telix Pharmaceuticals Limited Thu, Feb 13, 2025, 7:00 AM 5 min read ...
10d
Cade, Telix Group Chief Medical Officer, said, “Telix will feature in four presentations at this year’s ASCO GU, which showcase the depth and differentiation of our therapeutic urologic pipeline, ...
Dr. David N. Cade, Telix Group Chief Medical Officer, said, “Telix will feature in four presentations at this year’s ASCO GU, which showcase the depth and differentiation of our therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback